[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Alport Syndrome (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Alport Syndrome (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Alport Syndrome (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Alport Syndrome pipeline landscape...

April 2021 35 pages

Amine Oxidase [Flavin Containing] A (Monoamine Oxidase Type A or MAOA or EC 1.4.3.4) - Drugs in Development, 2021

 US$ 3,000.00

Amine Oxidase [Flavin Containing] A (Monoamine Oxidase Type A or MAOA or EC 1.4.3.4) - Drugs in Development, 2021 SUMMARY Amine Oxidase [Flavin Containing] A (Monoamine Oxidase Type A or MAOA or EC 1....

April 2021 35 pages

Amine Oxidase [Flavin Containing] B (Monoamine Oxidase Type B or MAOB or EC 1.4.3.4) - Drugs in Development, 2021

 US$ 3,000.00

Amine Oxidase [Flavin Containing] B (Monoamine Oxidase Type B or MAOB or EC 1.4.3.4) - Drugs in Development, 2021 SUMMARY Amine Oxidase [Flavin Containing] B (Monoamine Oxidase Type B or MAOB or EC 1....

April 2021 55 pages

Amino Acid Metabolism Disorders (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Amino Acid Metabolism Disorders (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Amino Acid Metabolism Disorders (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Am...

April 2021 30 pages

Anal Fissure (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Anal Fissure (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Anal Fissure (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Anal Fissure pipeline landscape. The repor...

April 2021 30 pages

Anaplastic Large Cell Lymphoma (ALCL) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Anaplastic Large Cell Lymphoma (ALCL) (Oncology) - Drugs in Development, 2021 SUMMARY Anaplastic Large Cell Lymphoma (ALCL) (Oncology) - Drugs in Development, 2021 provides an overview of the Anaplast...

April 2021 115 pages

Anaplastic Thyroid Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Anaplastic Thyroid Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Anaplastic Thyroid Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Anaplastic Thyroid Cancer pipeli...

April 2021 65 pages

Androgen Receptor (Dihydrotestosterone Receptor or Nuclear Receptor Subfamily 3 Group C Member 4 or DHTR or NR3C4 or AR) - Drugs in Development, 2021

 US$ 3,000.00

Androgen Receptor (Dihydrotestosterone Receptor or Nuclear Receptor Subfamily 3 Group C Member 4 or DHTR or NR3C4 or AR) - Drugs in Development, 2021 SUMMARY Androgen Receptor (Dihydrotestosterone Rec...

April 2021 160 pages

Androgen-Sensitive Prostate Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Androgen-Sensitive Prostate Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Androgen-Sensitive Prostate Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Androgen-Sensi...

April 2021 30 pages

Androgenic Alopecia (Dermatology) - Drugs in Development, 2021

 US$ 2,000.00

Androgenic Alopecia (Dermatology) - Drugs in Development, 2021 SUMMARY Androgenic Alopecia (Dermatology) - Drugs in Development, 2021 provides an overview of the Androgenic Alopecia pipeline landscape...

April 2021 50 pages

Anemia of Chronic Disease (Hematological Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Anemia of Chronic Disease (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Anemia of Chronic Disease (Hematological Disorders) - Drugs in Development, 2021 provides an overview of the An...

April 2021 30 pages

Angelman Syndrome (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Angelman Syndrome (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Angelman Syndrome (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Angelman Syndrome pipeline lan...

April 2021 50 pages

Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy (Oncology) - Drugs in Development, 2021 SUMMARY Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy (Oncolog...

April 2021 100 pages

Angiopoietin 2 (Ang 2 or ANGPT2) - Drugs in Development, 2021

 US$ 3,000.00

Angiopoietin 2 (Ang 2 or ANGPT2) - Drugs in Development, 2021 SUMMARY Angiopoietin 2 (Ang 2 or ANGPT2) - Drugs in Development, 2021 provides in depth analysis on Angiopoietin 2 (Ang 2 or ANGPT2) targe...

April 2021 45 pages

Angiopoietin Related Protein 3 (Angiopoietin 5 or Angiopoietin Like Protein 3 or ANG 5 or ANGPTL3) - Drugs in Development, 2021

 US$ 3,000.00

Angiopoietin Related Protein 3 (Angiopoietin 5 or Angiopoietin Like Protein 3 or ANG 5 or ANGPTL3) - Drugs in Development, 2021 SUMMARY Angiopoietin Related Protein 3 (Angiopoietin 5 or Angiopoietin L...

April 2021 35 pages

Angiosarcoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Angiosarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Angiosarcoma (Oncology) - Drugs in Development, 2021 provides an overview of the Angiosarcoma pipeline landscape. The report provides compr...

April 2021 50 pages

Angiotensin Converting Enzyme (Dipeptidyl Carboxypeptidase I or Kininase II or CD143 or ACE or EC 3.4.15.1 or EC 3.2.1.) - Drugs in Development, 2021

 US$ 3,000.00

Angiotensin Converting Enzyme (Dipeptidyl Carboxypeptidase I or Kininase II or CD143 or ACE or EC 3.4.15.1 or EC 3.2.1.) - Drugs in Development, 2021 SUMMARY Angiotensin Converting Enzyme (Dipeptidyl...

April 2021 40 pages

Anorexia Nervosa (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Anorexia Nervosa (Central Nervous System) - Drugs in Development, 2021 SUMMARY Anorexia Nervosa (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Anorexia Nervosa pipel...

April 2021 35 pages

Anterior Uveitis (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Anterior Uveitis (Ophthalmology) - Drugs in Development, 2021 SUMMARY Anterior Uveitis (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Anterior Uveitis pipeline landscape. The...

April 2021 45 pages

Anthrax Protective Antigen (pa) - Drugs in Development, 2021

 US$ 3,000.00

Anthrax Protective Antigen (pa) - Drugs in Development, 2021 SUMMARY Anthrax Protective Antigen (pa) - Drugs in Development, 2021 provides in depth analysis on Anthrax Protective Antigen (pa) targeted...

April 2021 35 pages

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) (Immunology) - Drugs in Development, 2021 SUMMARY Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculit...

April 2021 30 pages

Antiphospholipid Syndrome (Hematological Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Antiphospholipid Syndrome (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Antiphospholipid Syndrome (Hematological Disorders) - Drugs in Development, 2021 provides an overview of the An...

April 2021 30 pages

Antithrombin III (ATIII or SERPINC1) - Drugs in Development, 2021

 US$ 3,000.00

Antithrombin III (ATIII or SERPINC1) - Drugs in Development, 2021 SUMMARY Antithrombin III (ATIII or SERPINC1) - Drugs in Development, 2021 provides in depth analysis on Antithrombin III (ATIII or SER...

April 2021 35 pages

Anxiety Disorders (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Anxiety Disorders (Central Nervous System) - Drugs in Development, 2021 SUMMARY Anxiety Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Anxiety Disorders pi...

April 2021 140 pages

Aortic Valve Stenosis (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Aortic Valve Stenosis (Cardiovascular) - Drugs in Development, 2021 SUMMARY Aortic Valve Stenosis (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Aortic Valve Stenosis pipeli...

April 2021 35 pages

Apolipoprotein A (APOA or LPA) - Drugs in Development, 2021

 US$ 3,000.00

Apolipoprotein A (APOA or LPA) - Drugs in Development, 2021 SUMMARY Apolipoprotein A (APOA or LPA) - Drugs in Development, 2021 provides in depth analysis on Apolipoprotein A (APOA or LPA) targeted pi...

April 2021 30 pages

Apolipoprotein A I (APOA1) - Drugs in Development, 2021

 US$ 3,000.00

Apolipoprotein A I (APOA1) - Drugs in Development, 2021 SUMMARY Apolipoprotein A I (APOA1) - Drugs in Development, 2021 provides in depth analysis on Apolipoprotein A I (APOA1) targeted pipeline thera...

April 2021 35 pages

Apolipoprotein C III (APOC3) - Drugs in Development, 2021

 US$ 3,000.00

Apolipoprotein C III (APOC3) - Drugs in Development, 2021 SUMMARY Apolipoprotein C III (APOC3) - Drugs in Development, 2021 provides in depth analysis on Apolipoprotein C III (APOC3) targeted pipeline...

April 2021 35 pages

Apolipoprotein E (APOE) - Drugs in Development, 2021

 US$ 3,000.00

Apolipoprotein E (APOE) - Drugs in Development, 2021 SUMMARY Apolipoprotein E (APOE) - Drugs in Development, 2021 provides in depth analysis on Apolipoprotein E (APOE) targeted pipeline therapeutics....

April 2021 45 pages

Apolipoprotein L1 (Apolipoprotein L or APOL1) - Drugs in Development, 2021

 US$ 3,000.00

Apolipoprotein L1 (Apolipoprotein L or APOL1) - Drugs in Development, 2021 SUMMARY Apolipoprotein L1 (Apolipoprotein L or APOL1) - Drugs in Development, 2021 provides in depth analysis on Apolipoprote...

April 2021 30 pages

Apoptosis Regulator Bcl 2 (Protein Phosphatase 1 Regulatory Subunit 50 or BCL2) - Drugs in Development, 2021

 US$ 3,000.00

Apoptosis Regulator Bcl 2 (Protein Phosphatase 1 Regulatory Subunit 50 or BCL2) - Drugs in Development, 2021 SUMMARY Apoptosis Regulator Bcl 2 (Protein Phosphatase 1 Regulatory Subunit 50 or BCL2) - D...

April 2021 35 pages

Appetite (Eating) Disorders (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Appetite (Eating) Disorders (Central Nervous System) - Drugs in Development, 2021 SUMMARY Appetite (Eating) Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overview of the...

April 2021 35 pages

Aquaporin 4 (Mercurial Insensitive Water Channel or WCH4 or AQP4) - Drugs in Development, 2021

 US$ 3,000.00

Aquaporin 4 (Mercurial Insensitive Water Channel or WCH4 or AQP4) - Drugs in Development, 2021 SUMMARY Aquaporin 4 (Mercurial Insensitive Water Channel or WCH4 or AQP4) - Drugs in Development, 2021 pr...

April 2021 30 pages

Arachidonate 15 Lipoxygenase (12/15 Lipoxygenase or Arachidonate 12 Lipoxygenase Leukocyte Type or Arachidonate Omega 6 Lipoxygenase or ALOX15 or EC 1.13.11.33 or EC 1.13.11.31) - Drugs in Development, 2021

 US$ 3,000.00

Arachidonate 15 Lipoxygenase (12/15 Lipoxygenase or Arachidonate 12 Lipoxygenase Leukocyte Type or Arachidonate Omega 6 Lipoxygenase or ALOX15 or EC 1.13.11.33 or EC 1.13.11.31) - Drugs in Development...

April 2021 30 pages

Arachidonate 5 Lipoxygenase (5 Lipoxygenase or Leukotriene A4 Synthase or ALOX5 or EC 1.13.11.34) - Drugs in Development, 2021

 US$ 3,000.00

Arachidonate 5 Lipoxygenase (5 Lipoxygenase or Leukotriene A4 Synthase or ALOX5 or EC 1.13.11.34) - Drugs in Development, 2021 SUMMARY Arachidonate 5 Lipoxygenase (5 Lipoxygenase or Leukotriene A4 Syn...

April 2021 40 pages

Arachidonate 5 Lipoxygenase Activating Protein (MK 886 Binding Protein or FLAP or ALOX5AP) - Drugs in Development, 2021

 US$ 3,000.00

Arachidonate 5 Lipoxygenase Activating Protein (MK 886 Binding Protein or FLAP or ALOX5AP) - Drugs in Development, 2021 SUMMARY Arachidonate 5 Lipoxygenase Activating Protein (MK 886 Binding Protein o...

April 2021 30 pages

Arenaviridae Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Arenaviridae Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Arenaviridae Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Arenaviridae Inf...

April 2021 30 pages

Arginase 1 (Liver Type Arginase or Type I Arginase or ARG1 or EC 3.5.3.1) - Drugs in Development, 2021

 US$ 3,000.00

Arginase 1 (Liver Type Arginase or Type I Arginase or ARG1 or EC 3.5.3.1) - Drugs in Development, 2021 SUMMARY Arginase 1 (Liver Type Arginase or Type I Arginase or ARG1 or EC 3.5.3.1) - Drugs in Deve...

April 2021 30 pages

Aromatase (Estrogen Synthase or Cytochrome P 450AROM or Cytochrome P450 19A1 or CYP19A1 or EC 1.14.14.14) - Drugs in Development, 2021

 US$ 3,000.00

Aromatase (Estrogen Synthase or Cytochrome P 450AROM or Cytochrome P450 19A1 or CYP19A1 or EC 1.14.14.14) - Drugs in Development, 2021 SUMMARY Aromatase (Estrogen Synthase or Cytochrome P 450AROM or C...

April 2021 35 pages

Aromatic L Amino Acid Decarboxylase (AADC or Dopa Decarboxylase or DDC or EC 4.1.1.28) - Drugs in Development, 2021

 US$ 3,000.00

Aromatic L Amino Acid Decarboxylase (AADC or Dopa Decarboxylase or DDC or EC 4.1.1.28) - Drugs in Development, 2021 SUMMARY Aromatic L Amino Acid Decarboxylase (AADC or Dopa Decarboxylase or DDC or EC...

April 2021 50 pages

Arteriosclerosis (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Arteriosclerosis (Cardiovascular) - Drugs in Development, 2021 SUMMARY Arteriosclerosis (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Arteriosclerosis pipeline landscape. T...

April 2021 35 pages

Arthritis (Musculoskeletal) - Drugs in Development, 2021

 US$ 2,000.00

Arthritis (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Arthritis (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Arthritis pipeline landscape. The report provides...

April 2021 105 pages

Articular Cartilage Defect (Musculoskeletal) - Drugs in Development, 2021

 US$ 2,000.00

Articular Cartilage Defect (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Articular Cartilage Defect (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Articular Cartil...

April 2021 35 pages

Arylsulfatase A (Cerebroside Sulfatase or ASA or ARSA or EC 3.1.6.8) - Drugs in Development, 2021

 US$ 3,000.00

Arylsulfatase A (Cerebroside Sulfatase or ASA or ARSA or EC 3.1.6.8) - Drugs in Development, 2021 SUMMARY Arylsulfatase A (Cerebroside Sulfatase or ASA or ARSA or EC 3.1.6.8) - Drugs in Development, 2...

April 2021 35 pages

Ascites (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Ascites (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Ascites (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Ascites pipeline landscape. The report provides comp...

April 2021 30 pages

Aspartoacylase (Aminoacylase 2 or ACY2 or ASPA or EC 3.5.1.15) - Drugs in Development, 2021

 US$ 3,000.00

Aspartoacylase (Aminoacylase 2 or ACY2 or ASPA or EC 3.5.1.15) - Drugs in Development, 2021 SUMMARY Aspartoacylase (Aminoacylase 2 or ACY2 or ASPA or EC 3.5.1.15) - Drugs in Development, 2021 provides...

April 2021 35 pages

Astrocytoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Astrocytoma (Oncology) - Drugs in Development, 2021 SUMMARY Astrocytoma (Oncology) - Drugs in Development, 2021 provides an overview of the Astrocytoma pipeline landscape. The report provides comprehe...

April 2021 55 pages

Ataxin 3 (Machado Joseph Disease Protein 1 or Spinocerebellar Ataxia Type 3 Protein or SCA3 or ATXN3 or EC 3.4.19.12) - Drugs in Development, 2021

 US$ 3,000.00

Ataxin 3 (Machado Joseph Disease Protein 1 or Spinocerebellar Ataxia Type 3 Protein or SCA3 or ATXN3 or EC 3.4.19.12) - Drugs in Development, 2021 SUMMARY Ataxin 3 (Machado Joseph Disease Protein 1 or...

April 2021 35 pages

Atopic Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Atopic Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021 SUMMARY Atopic Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Atopic Keratoconju...

April 2021 30 pages

ATP Dependent Clp Protease Proteolytic Subunit Mitochondrial (Endopeptidase Clp or CLPP or EC 3.4.21.92) - Drugs in Development, 2021

 US$ 3,000.00

ATP Dependent Clp Protease Proteolytic Subunit Mitochondrial (Endopeptidase Clp or CLPP or EC 3.4.21.92) - Drugs in Development, 2021 SUMMARY ATP Dependent Clp Protease Proteolytic Subunit Mitochondri...

April 2021 30 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1